- Home
- VTVT vs ORGN Comparison
VTVT vs ORGN Comparison
Compare VTVT & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTVT | ORGN |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0M | 109.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | VTVT | ORGN |
|---|---|---|
| Price | $39.90 | $0.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $43.50 | N/A |
| AVG Volume (30 Days) | 12.8K | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,000.00 | ★ $25,122,000.00 |
| Revenue This Year | N/A | $49.18 |
| Revenue Next Year | N/A | $144.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.20 | $0.19 |
| 52 Week High | $41.49 | $1.36 |
Technical Indicators
Market Signals| Indicator | VTVT | ORGN |
|---|---|---|
| Relative Strength Index (RSI) | 74.14 | 25.80 |
| Support Level | $33.62 | $0.19 |
| Resistance Level | $41.49 | $0.46 |
| Average True Range (ATR) | 2.16 | 0.03 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 78.61 | 13.59 |
Price Performance
Historical ComparisonAbout VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.